Document:

Exhibit
10.1

    

    English
Translation of the Share Purchase Agreement

    

    by
and between

    

    
      Wealth
Chance Investments Ltd.(the
“Investor”)

      

      and

      

      China
Polypeptide Group, Inc. ( the “Company”)

       

    

    SHARE
PURCHASE AGREEMENT

    

    Dated
August 25, 2010

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     This Agreement is made on
August 25, 2010 by and between the following parties:

    

    
      	
            	
              o

            	
              China Polypeptide Group, Inc.
      (the “Company”); and

            

    

    

    
      	
            	
              o

            	
              Wealth Chance Investments
      Ltd.(the “Investor”)

            

    

    

    After
friendly discussion and negotiation, in the principle of mutual benefits and
cooperation, the parties agree as follows:

    

    Section
1 - Investment Amount and Purchase of Shares

    Following
five (5) days of the execution of this Agreement, the Investor will purchase
585,743 common shares of the Company by delivering to the Company, in one lump
sum, USD$3 million in cash.

    

    Section
2 - Warrant

    Upon the
payment by the Investor, the Company will issue to the Investor a Warrant to
purchase 87,861 common shares of the Company in the future.  The term
of the Warrant is five years and the exercise price of the Warrant is USD$6.75
per share.

    

    Section
3 - Right of Participation

    The
common shares held by the Investor shall have the right to participate in any
profit distribution by the Company as other common shares held by the original
shareholders.

    

    Section
4 - Registration Right

    The
Company promises to register, by the six-month anniversary of the completion of
this Investment, all the restricted shares held by the Investor with the
relevant U.S. securities exchange agency so that such shares can be converted
into non-restricted shares.  If, then, the relevant U.S. securities
exchange agency demands any adjustment of the number of such shares to be
registered, the Investor should accept such adjustment.

    

    Section
5 - Allocation and Use of Investment Proceeds

    The
Company agrees to have the Investment Proceeds to be transferred into the
following bank account: Account Name: _____________, Account Number: __________,
Bank Address: ________. Such Investment Proceeds of the Company will be used for
the expansion of the Company’s production facility. If used for other purposes,
a prior consent from the Investor should be obtained.

    

    Section
6 - Restriction on Share Transfer

    The
Investor agrees to a lock-up period of six months (calculated from the date of
the public offering) when the Company next undertakes a public offering provided
that the original principal shareholders of the Company are also subject to the
lock-up requirement. Upon the expiration of the lock-up period, the Company
shall make sure the Investor can trade the common shares held by it in the
secondary market without restriction.  Detailed measures of trading
shall be decided to minimize the impact on public offering with the
underwriter.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    Section
7 - Priority in Share Transfer

    Before
the Investor has transferred his shares, if the original principal shareholders
of the Company will transfer any of their shares in the Company, the Investor
has priority right in share transfer.

    

    Section
8 - Right of First Refusal

    The
Investor shall have the right of first refusal with respect to any new shares to
be issued by the Company (If the original shareholders decide not to purchase
the new shares, the Investor shall have the right to purchase such
shares.).

    

    Section
9 - Confidentiality

    The
parties agree to maintain the confidentiality of this Agreement, discussions
thereof and the intentions of the Investor before the Investor completes its
capital contribution and not to disclose such information to any third party
unless the disclosure is made to the legal counsel, financial consultant,
investment bank, auditor or accountant of the parties or required by
law.  Prior consents of both the Investor and the Company are required
before public announcement of any information in connection with the transaction
thereof.

    

    Section
10- Governing Law

    This
Agreement shall be governed by the laws of Hong Kong.  Any dispute
regarding the Agreement shall be settled by arbitration in Hong Kong at the Hong
Kong International Arbitration Center in accordance with the arbitration rules
in effect.

    

    Section
11 - Effectiveness

    This
Agreement shall be executed in four copies and shall become effective upon
execution by the parties.

    

    In
witness thereof, the authorized representatives of the parties have executed
this Agreement as of the date first written above:

    

    Company:        China Polypeptide Group,
Inc.

    

    Name:

    

    Position:

    

    Signature:

    

    Investor:          Wealth Chance Investments
Ltd.

    

    Name:

    

    Position:

    

    Signature:Unassociated Document

     

    FOR IMMEDIATE
RELEASE

     

     

    August
30, 2010

     

     

    Contact
Investor Relations:

     

    William
McKay, Chief Executive Officer

    626-755-1211

    wrmckay@gmail.com

    Website:
www.transpacificaerospace.com

     

     

    Trans-Pacific
Aerospace Company, Inc.
Appoints Kevin Gould to Board of Directors; Aerospace Veteran Joins the
Team

     

     

    SAN JUAN CAPISTRANO, CA-- (Businesswire
) - Trans-Pacific Aerospace Company, Inc. (OTC.BB:TPAC - News) announced today that it has appointed
Kevin Gould, an aerospace veteran from Boeing, Adam Aircraft Industries and
Piper Aircraft, to serve on its board of directors.

     

    Kevin
Gould served as President and CEO of airplane manufacturer Piper Aircraft since
early 2009.  During that time, the company doubled its market share,
elevated spare parts fill rates by outsourcing their distribution to Aviall,
successfully introduced the two-seat PiperSport by partnering with manufacturer
Czech Sport Aircraft, overhauled and globalized its sales and distribution
channel, initiated Facebook/YouTube/Twitter marketing programs, cut SG&A
through innovative restructuring of its product liability risk management, and
re-launched development of its PiperJet aircraft.

    

    Prior to
becoming CEO, Kevin Gould was VP of Operations at Piper from
2005-2009.  As such, he was a member of the executive team that turned
around and sold the company to a foreign sovereign wealth
fund.  During his tenure as VP of Operations, the company reorganized
its manufacturing operations, increased on-time deliveries from 50% to 99%,
reduced labor costs 20%, decreased material costs 10%, cut cycle times 50%
(resulting in working capital reductions of $7m), and improved quality by
50%.

    

    Previously,
Kevin Gould was VP of Operations at startup aircraft manufacturer Adam
Aircraft.  There he set up production operations for the company's
carbon fiber piston and jet airplanes.  Before joining Adam Aircraft,
Kevin acquired, turned around and sold healthcare documentation startup
Clinicient which provides internet-based documentation and billing services to
the physical therapy industry.  Earlier, Kevin spent 12 years in
various management and executive positions at Boeing, managing manufacturing,
engineering, financial and facilities functions in the commercial aircraft
division of the company.  In his last assignment at Boeing, he formed
and led the business unit that designed, manufactured and procured all wire
harnesses and electrical components for the company's 777, 747, 767, 737 and 757
commercial aircraft.  Prior to Boeing, Kevin spent 3 years managing
production and finance functions at Hewlett-Packard's signal generator and radio
frequency analyzer test division.  He also spent 3 years as an
attorney at a major Los Angeles law firm, practicing business and real estate
law.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    "We're thrilled that Kevin has joined
the board of directors," said Bill
McKay, Trans-Pacific
Aerospace CEO. "We are searching for board members with industry experience,
expertise and contacts to enhance the profile of Trans-Pacific Aerospace
Company.  Kevin has all of these qualities in addition to a strong
background in foreign
sourcing of aerospace products.  We plan on tapping Kevin’s knowledge and skills in order to
improve and grow the company.  We are confident that Kevin will help
us tremendously in executing our business plan.  As Trans-Pacific
develops new product lines for applications in China
we believe that Kevin, who has an established relationship with AVIC, will be
able to work with AVIC and several of China's new super ministries, which we
hope will give us a marketable advantage in the Chinese aerospace sector."

     

    Kevin has
served on several boards of directors including Piper Aircraft, General Aviation
Manufacturers Association (executive committee and chairman of Product Liability
committee), BECU ($4 Billion financial institution) and United Way of Snohomish
County.  He holds an MBA from Harvard University, a MS in management
from Stanford University's Sloan program, a JD from University of Southern
California and a BA from Washington State University.  He has a wife
and two grown children and enjoys tennis, skiing, flying, motorcycling and
automobiles.  He is an instrument rated pilot.

     

    Trans-Pacific
Aerospace Company plans to
use its proprietary aerospace bearing technologies to manufacture and sell
component parts for both new commercial aircraft and spares for the existing
commercial fleet, initially through a joint venture in China. The component
parts are referred to as self-lubricating spherical bearings,
and they help with several flight critical tasks including aircraft flight
controls and landing gears.

     

    Information About Forward-Looking
Statements

     

    This press release contains or
incorporates by reference "forward-looking statements" including certain
information with respect to plans and strategies of Trans-Pacific Aerospace
Company, Inc. For this purpose, any statements contained herein or incorporated
herein by references that are not statements of historical fact may be deemed forward looking statements.
Without limiting the foregoing, the words "believes," "suggests," "anticipates,"
"plans," "expects," and similar expressions are intended to identify forward
looking statements. There are a number of events or actual results of Trans-Pacific Aerospace
Company, Inc. operations that could differ materially from those indicated by
such forward-looking statements.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}]]